Literature DB >> 14126061

EFFECT OF HEXADIMETHRINE BROMIDE ON PLASMA KININ FORMATION, HYDROLYSIS OF P-TOSYL-L-ARGININE METHYL ESTER AND FIBRINOLYSIS.

V EISEN.   

Abstract

The antiheparin agent hexadimethrine bromide, in concentrations of 20 to 200 mug/ml., inhibited the activation by active Hageman factor of the plasma enzyme which releases kinin from substrate. Once activated, this kinin-forming enzyme was not consistently inhibited by hexadimethrine in a concentration of 1 mg/ml. Surfaces which induce kinin formation by activating Hageman factor in plasma (glass, kaolin, celite, barium carbonate and carboxymethylcellulose) were inactivated by bathing in aqueous solutions of hexadimethrine. The effects of hexadimethrine on Hageman factor and on glass were not abolished by amounts of heparin which neutralize most other actions of hexadimethrine. Hexadimethrine prevented the activation by kaolin, but not by streptokinase, of p-tosyl-L-arginine methyl ester-splitting and fibrinolytic factors in plasma; once these enzymes were activated by kaolin, they could not be inhibited by hexadimethrine. Hexadimethrine, given locally or intravenously into guinea-pigs, reduced the increase in capillary permeability produced by intracutaneous injections of kaolin suspensions.

Entities:  

Keywords:  ARGININE; BLOOD CHEMICAL ANALYSIS; BLOOD COAGULATION FACTORS; ENZYME INHIBITORS; EXPERIMENTAL LAB STUDY; FACTOR XII; FIBRINOLYSIS; HEPARIN ANTAGONISTS; PEPTIDES; PHARMACOLOGY; RATS

Mesh:

Substances:

Year:  1964        PMID: 14126061      PMCID: PMC1703902          DOI: 10.1111/j.1476-5381.1964.tb01546.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  24 in total

1.  Relationship between air temperature and mean radiant temperature in thermal comfort.

Authors:  W KOCH
Journal:  Nature       Date:  1962-11-10       Impact factor: 49.962

2.  The purification of activated Hageman factor (activated factor XII).

Authors:  O D RATNOFF; E W DAVIE
Journal:  Biochemistry       Date:  1962-11       Impact factor: 3.162

3.  The interrelationship of coagulation of plasma and release of peptides.

Authors:  J MARGOLIS
Journal:  Ann N Y Acad Sci       Date:  1963-02-04       Impact factor: 5.691

4.  Activation of Hagemen Factor by saturated fatty acids.

Authors:  J MARGOLIS
Journal:  Aust J Exp Biol Med Sci       Date:  1962-12

5.  Studies on plasma kallikrein and its relationship to plasmin.

Authors:  M E WEBSTER; J V PIERCE
Journal:  J Pharmacol Exp Ther       Date:  1960-12       Impact factor: 4.030

6.  Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent.

Authors:  O D RATNOFF; E W DAVIE; D L MALLETT
Journal:  J Clin Invest       Date:  1961-05       Impact factor: 14.808

7.  Measurement of the rate of plasmin action on synthetic substrates.

Authors:  P S ROBERTS
Journal:  J Biol Chem       Date:  1958-05       Impact factor: 5.157

8.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

9.  Observations on intrinsic kinin-forming factors in human plasma: the effect of acid, acetone, chloroform, heat and euglobulin separation on kinin formation.

Authors:  V Eisen
Journal:  J Physiol       Date:  1963-05       Impact factor: 5.182

10.  Activation of endogenous plasma proteolytic enzymes with the consequent production of pharmacologically active polypeptides.

Authors:  M MACKAY; W D MAYCOCK; B S COMBRIDGE
Journal:  Nature       Date:  1962-09-22       Impact factor: 49.962

View more
  14 in total

1.  ON THE ANTI-INFLAMMATORY ACTIVITY OF PROTAMINE SULPHATE AND OF HEXADIMETHRINE BROMIDE, INHIBITORS OF PLASMA KININ FORMATION.

Authors:  D N KELLETT
Journal:  Br J Pharmacol Chemother       Date:  1965-06

2.  Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.

Authors:  R W Colman; L Mattler; S Sherry
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

3.  Two functionally different kininogens in human plasma.

Authors:  G Seidel
Journal:  Agents Actions       Date:  1973-05

4.  Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors.

Authors:  D Ogston; C M Ogston; O D Ratnoff; C D Forbes
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

5.  The effects of temperature on the response of human plasma kinin-forming system to promoting and inhibiting agents.

Authors:  D Armstrong
Journal:  Br J Pharmacol       Date:  1968-11       Impact factor: 8.739

6.  On the mechanism of the anti-inflammatory activity of hexadimethrine bromide.

Authors:  D N Kellett
Journal:  Br J Pharmacol Chemother       Date:  1966-02

7.  The isolation of human plasma prekallikrein.

Authors:  D J McConnell; B Mason
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

8.  Effect of cellulose sulphate on serum complement.

Authors:  V Eisen; C Loveday
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

9.  Inhibition of Hageman factor activation.

Authors:  H L Nossel; H Rubin; M Drillings; R Hsieh
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

10.  Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein.

Authors:  C G Cochrane; S D Revak; K D Wuepper
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.